Efficacy and Safety Study of Ulipristal Acetate in Females With Anemia Associated With Uterine Leiomyoma

Withdrawn before enrolling · Phase 3 · Has a placebo group

Conditions studied: Leiomyomas

In brief

The purpose of this study is to determine whether ulipristal acetate is effective in the treatment of females with anemia associated with uterine leiomyomas. The safety of this product will also be evaluated.

Key facts

Study ID
NCT01553123
Run by
Watson Pharmaceuticals
People needed
0
Starts
2012-04-01
Expected to finish
2013-12-01
Last updated by the study team
2013-02-07

Who can join

Age: 18 and older, up to 50. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.